Literature DB >> 1705708

Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.

U Förstermann1, J S Pollock, H H Schmidt, M Heller, F Murad.   

Abstract

Endothelium-derived relaxing factor/nitric oxide (EDRF/NO) synthesized by bovine aortic endothelial cells and subcellular fractions thereof was assayed by its stimulating effect on soluble guanylyl cyclase of rat fetal lung fibroblasts (RFL-6 cells). The release of EDRF/NO by intact endothelial cells could be stimulated with bradykinin, thrombin, or ADP and was abolished in Ca2(+)-free medium. When subcellular fractions were analyzed, some EDRF/NO-synthesizing activity was found in the cytosolic fraction, but most of the activity was associated with the particulate fraction. Both enzyme activities required L-arginine and NADPH for EDRF/NO synthesis, both were inhibited by NG-nitro-L-arginine and NG-methyl-L-arginine, and hemoglobin or methylene blue abolished the effect of the EDRF/NO produced by both enzymes. Both enzymes were highly sensitive to Ca2+; the major increase in activity occurred between 100 and 500 nM free Ca2+. Exposure of the particulate enzyme activity to 1 M KCl removed 39% of the protein and reduced total activity by 46%, but the activity was restored when exogenous calmodulin (CaM) was added. Further KCl washes caused little further loss of protein or EDRF/NO synthase activity. The KCl-washed particulate enzyme could be solubilized with the detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate. The CaM antagonists calmidazolium and trifluoperazine as well as the CaM-binding protein calcineurin inhibited the EDRF/NO synthesis by both the cytosolic and the particulate enzyme. These effects were partially reversed with exogenous CaM. Partial purification of the cytosolic and solubilized particulate enzymes by affinity chromatography on adenosine 2',5'-bisphosphate-Sepharose resulted in EDRF/NO synthase activities dependent on exogenous CaM. We conclude that endothelial cells contain both cytosolic and particulate enzymes that synthesize EDRF/NO. Both enzymes are regulated by free Ca2+ and, at least in part, by CaM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705708      PMCID: PMC51110          DOI: 10.1073/pnas.88.5.1788

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The cytosol of N1E-115 neuroblastoma cells synthesizes an EDRF-like substance that relaxes rabbit aorta.

Authors:  U Förstermann; K Ishii; L D Gorsky; F Murad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

2.  Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.

Authors:  A L Steiner; C W Parker; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

3.  Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries.

Authors:  U Förstermann; A Mülsch; E Böhme; R Busse
Journal:  Circ Res       Date:  1986-04       Impact factor: 17.367

Review 4.  Cyclic guanosine monophosphate as a mediator of vasodilation.

Authors:  F Murad
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

5.  Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.

Authors:  T J Rimele; R J Sturm; L M Adams; D E Henry; R J Heaslip; B M Weichman; D Grimes
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

6.  Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase.

Authors:  H H Schmidt; J S Pollock; M Nakane; L D Gorsky; U Förstermann; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

7.  Arginine is a physiological precursor of endothelium-derived nitric oxide.

Authors:  H H Schmidt; H Nau; W Wittfoht; J Gerlach; K E Prescher; M M Klein; F Niroomand; E Böhme
Journal:  Eur J Pharmacol       Date:  1988-09-13       Impact factor: 4.432

8.  Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets.

Authors:  U Alheid; J C Frölich; U Förstermann
Journal:  Thromb Res       Date:  1987-09-01       Impact factor: 3.944

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.

Authors:  L J Ignarro; R G Harbison; K S Wood; P J Kadowitz
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

View more
  123 in total

Review 1.  Molecular mechanisms of estrogen actions on the vasculature.

Authors:  M P Haynes; K S Russell; J R Bender
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

2.  Stimulus-specific alteration of the relationship between cytosolic Ca(2+) transients and nitric oxide production in endothelial cells ex vivo.

Authors:  O Mizuno; S Kobayashi; K Hirano; J Nishimura; C Kubo; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

3.  Nω-NITRO-Nω'-SUBSTITUTED GUANIDINES: A SIMPLE CLASS OF NITRIC OXIDE SYNTHASE INHIBITORS.

Authors:  Christophe D Guillon; David D Wisnoski; Jaya Saxena; Ned D Heindel; Diane E Heck; Donald J Wolff; Jeffrey D Laskin
Journal:  Mod Res Inflamm       Date:  2014-05

4.  Nitric oxide synthase in ferret brain: localization and characterization.

Authors:  T Matsumoto; J A Mitchell; H H Schmidt; K L Kohlhaas; T D Warner; U Förstermann; F Murad
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

5.  Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.

Authors:  K Nishida; D G Harrison; J P Navas; A A Fisher; S P Dockery; M Uematsu; R M Nerem; R W Alexander; T J Murphy
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  Characterization and localization of nitric oxide synthase in non-adrenergic non-cholinergic nerves from bovine retractor penis muscles.

Authors:  H Sheng; H H Schmidt; M Nakane; J A Mitchell; J S Pollock; U Föstermann; F Murad
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

7.  Endothelial cell-derived nitric oxide enhances aerobic glycolysis in astrocytes via HIF-1α-mediated target gene activation.

Authors:  Britta Brix; Jeroen R Mesters; Luc Pellerin; Olaf Jöhren
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

8.  Inhibitors caveolin-1 and protein kinase G show differential subcellular colocalization with Nitric oxide synthase.

Authors:  T J Adebola; Raj Usha
Journal:  Afr Health Sci       Date:  2011-12       Impact factor: 0.927

9.  Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.

Authors:  Y Hirata; T Emori; S Eguchi; K Kanno; T Imai; K Ohta; F Marumo
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Regulation of baseline vascular resistance in the canine diaphragm by nitric oxide.

Authors:  M E Ward; S N Hussain
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.